Latest Breaking News On - Jasko terzic - Page 1 : comparemela.com

EQS-Adhoc: SCHOTT Pharma AG & Co KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes - adhoc - Börsennachrichten

EQS-Adhoc: SCHOTT Pharma AG & Co KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes - adhoc - Börsennachrichten
stock-world.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stock-world.de Daily Mail and Mail on Sunday newspapers.

Jasko terzicJoana kornblum

SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from s

SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from s
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United statesJoana kornblumAlmuth steinkJasko terzicCarl zeiss foundationFrankfurt stock exchangeDrug containment solutionsPharma ag coDistribution servicesPreliminary resultsDrug delivery systemsSouth americaCarl zeissCorporate newsRegulatory announcements

SCHOTT Pharma AG & Co KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes

SCHOTT Pharma AG & Co KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Jasko terzicJoana kornblumSchott pharma ag coDistribution servicesPharma ag coRegulatory announcementsCorporate news

SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word: Personnel SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations 30.04.2024 / 17:00 CET/CEST The issuer.

United statesJoana kornblumJasko terzicTobias erfurthAlmuth steinkInvestor relations teamFrankfurt stock exchangePharma ag coCarl zeiss foundationDresdner bankInvestor relationsCrop energiesSouth americaCarl zeiss

EQS-News: SCHOTT Pharma reports good start into fiscal year 2024

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Quarterly / Interim Statement/Quarter Results SCHOTT Pharma reports.

United statesJasko terzicJoana kornblumAndreas reisseAlmuth steinkCarl zeiss foundationDrug containment solutionsPharma ag coRevenues for the drug containment solutionsFrankfurt stock exchangeDrug delivery systemsSouth americaCarl zeiss